Search results

30 results found

… group, blood group antibodies and transfusion-transmissible pathogens. Donor eligibility criteria and testing also … process, the testing done on donated blood, and the pathogen inactivation processes that can further reduce risk … virus and all cellular blood components are leukoreduced in Canada, the risk of transfusion-related CMV …
July 25, 2024
…   Discuss basic concepts and methods for inactivation of pathogens in blood products. 2.    Review literature on … clinical performance of PRT treated products. 3.    Discuss pathogen reduction performance levels and clinical outcomes … 2.    Estcourt LJ, Malouf R, Hopewell S, et al. Pathogen-reduced platelets for the prevention of bleeding. Cochrane …
September 7, 2023
June 14, 2024
… on Canadian Blood Services platelet bacterial screening . Pathogen inactivation adds an extra layer of protection against a number of pathogens, including bacteria and viruses. By effectively … transmission. See Chapter 19 for more about pathogen-reduced platelets.   Dyspnea Dyspnea or hypoxemia can occur …
June 17, 2024
March 22, 2023
… associations (WHO, WFH, IPOPI, IPFA, PPTA) and suppliers of pathogen reduction technologies & plasma processing devices … therapeutic plasma proteins: quarantine/retested plasma; pathogen-reduced plasma, cryo-poor plasma, and …
September 7, 2023
… Chapter 6 on donor selection, donor testing and pathogen reduction . Blood donors play an essential role … via the donor questionnaire (e.g.,  Trypanosoma cruzi , the pathogen which causes Chagas disease). 10  More detailed … in Chapter 6 on donor selection, donor testing and pathogen reduction . 11   In addition to testing blood …
December 4, 2024